Procaps Group S.A.
NASDAQ:PROC
Overview | Financials
Company Name | Procaps Group S.A. |
Symbol | PROC |
Currency | USD |
Price | 2.35 |
Market Cap | 265,136,400 |
Dividend Yield | 0% |
52-week-range | 0.5 - 4.95 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Ruben Minski |
Website | https://www.procapsgroup.com |
An error occurred while fetching data.
About Procaps Group S.A.
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD